Medical application lowering A1c and improving T2DM drugs

Jehovah’s Witnesses Allow Autologous Blood in Brazil

Jehovah’s Witnesses now allow members to choose to use their own blood in some procedures, reigniting debate over bloodless surgery, patient autonomy, and broader blood-conservation care.

Clopidogrel Beats Aspirin Long-Term After PCI

When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding events relative to aspirin.

BP After Stroke Thrombectomy: Individualization Needed?

Results of a new trial suggest that BP targets after thrombectomy in patients with acute ischemic stroke may need to be individualized depending on several different patient characteristics.

Too Few Children With Overweight/Obesity Assessed for OSA

Children were more likely to undergo an evaluation if they had public insurance, had a higher BMI, had English as a primary language, or were a toddler or preschool aged.

New STEMI Score Predicts Mortality After Angioplasty

A new seven factor score predicts long term mortality after ST-elevation myocardial infarction in patients who undergo angioplasty, and it performs similarly to or better than existing models.

Lipoprotein(a) Levels Matter Even in Primary Prevention

Elevated lipoprotein(a) levels are associated with increased non-calcified plaque volume and higher odds of high-risk features at the plaque level in adults without prior coronary artery disease.

Syncing Sleep, Fasting Improves Blood Sugar Markers

Patients interested in time-restricted eating should make sense it works their own sleep cycle.

Severe Chest Pain in Newly Diagnosed Colorectal Cancer

Case study illustrates iatrogenic risks not to be underestimated

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

ACC: American College of Cardiology

HRS: Heart Rhythm Society

Exercise According to Chronotrope Type; Estimating Kidney Function

Also in TTHealthWatch: deprescribing proton pump inhibitors